摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-Oxy-benzyl)-o-phenylendiamin | 7229-53-0

中文名称
——
中文别名
——
英文名称
N-(2-Oxy-benzyl)-o-phenylendiamin
英文别名
2-(2-Amino-anilinomethyl)-phenol;N-(2-hydroxybenzyl)-o-phenylenediamine;2-[(2-Aminoanilino)methyl]phenol
N-(2-Oxy-benzyl)-o-phenylendiamin化学式
CAS
7229-53-0
化学式
C13H14N2O
mdl
——
分子量
214.267
InChiKey
PARUQVNBVVOVQQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    155-157 °C
  • 沸点:
    411.3±30.0 °C(Predicted)
  • 密度:
    1.258±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    58.3
  • 氢给体数:
    3
  • 氢受体数:
    3

SDS

SDS:91bc93d25e0b7670f31cd8ea754c4700
查看

反应信息

  • 作为反应物:
    描述:
    chloroacetic acid imino ether hydrochloride 、 N-(2-Oxy-benzyl)-o-phenylendiamin氯仿 为溶剂, 生成 2-chloromethyl-1-(2-hydroxybenzyl)-benzimidazole
    参考文献:
    名称:
    Benzimidazole derivatives and process for the production thereof
    摘要:
    Benzimidazoles的化学式为##STR1##,其中R.sub.1为o-羟基苯基、p-氯苯基或p-氟苯基,R.sub.2为2-4个碳原子的烷基,以及其生理上可接受的酸盐具有局部抗炎活性。
    公开号:
    US04011322A1
  • 作为产物:
    描述:
    2-((2-aminophenylimino)methyl)phenol甲醇 、 sodium tetrahydroborate 作用下, 反应 3.0h, 以88%的产率得到N-(2-Oxy-benzyl)-o-phenylendiamin
    参考文献:
    名称:
    Inhibition of copper-mediated aggregation of human γD-crystallin by Schiff bases
    摘要:
    Protein aggregation, due to the imbalance in the concentration of Cu2+ and Zn2+ ions is found to be allied with various physiological disorders. Copper is known to promote the oxidative damage of beta/gamma-crystallins in aged eye lens and causes their aggregation leading to cataract. Therefore, synthesis of a small-molecule 'chelator' for Cu2+ with complementary antioxidant effect will find potential applications against aggregation of beta/gamma-crystallins. In this paper, we have reported the synthesis of different Schiff bases and studied their Cu2+ complexation ability (using UV-Vis, FT-IR and ESI-MS) and antioxidant activity. Further based on their copper complexation efficiency, Schiff bases were used to inhibit Cu2+-mediated aggregation of recombinant human gamma D-crystallin (HGD) and beta/gamma-crystallins (isolated from cataractous human eye lens). Among these synthesized molecules, compound 8 at a concentration of 100 mu M had shown 95% inhibition of copper (100 mu M)-induced aggregation. Compound 8 also showed a positive cooperative effect at a concentration of 5-15 mu M on the inhibitory activity of human alpha A-crystallin (HAA) during Cu2+-induced aggregation of HGD. It eventually inhibited the aggregation process by additional 20%. However, 50% inhibition of copper-mediated aggregation of beta/gamma-crystallins (isolated from cataractous human eye lens) was recorded by compound 8 (100 mu M). Although the reductive aminated products of the imines showed better antioxidant activity due to their lower copper complexing ability, they were found to be non-effective against Cu2+-mediated aggregation of HGD.
    DOI:
    10.1007/s00775-016-1433-0
点击查看最新优质反应信息

文献信息

  • Paal; Reckleben, Chemische Berichte, 1895, vol. 28, p. 934
    作者:Paal、Reckleben
    DOI:——
    日期:——
  • 3-AMINO-2-AMINOMETHYLPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS
    申请人:Wella Aktiengesellschaft
    公开号:EP1846361A2
    公开(公告)日:2007-10-24
  • US4011322A
    申请人:——
    公开号:US4011322A
    公开(公告)日:1977-03-08
  • [EN] 3-AMINO-2-AMINOMETHYLPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS<br/>[FR] DERIVES DE 3-AMINO-2-AMINOMETHYLPHENOL ET COLORANTS CONTENANT CES COMPOSES
    申请人:PROCTER & GAMBLE
    公开号:WO2006086374A2
    公开(公告)日:2006-08-17
    [EN] 3-Amino-2-aminomethylphenol derivatives of the general formula (I) or physiologically compatible, water-soluble salts thereof, and agent comprising these compounds for the oxidative coloring of keratin fibers.
    [FR] L'invention porte sur des dérivés de 3-amino-2-aminomethylphenol représentés par la formule (I) ou sur des sels hydrosolubles de ceux-ci physiologiquement compatibles, ainsi que sur un agent contenant ces composés pour la coloration oxydante de fibres de kératine.
  • Inhibition of copper-mediated aggregation of human γD-crystallin by Schiff bases
    作者:Priyanka Chauhan、Sai Brinda Muralidharan、Anand Babu Velappan、Dhrubajyoti Datta、Sanjay Pratihar、Joy Debnath、Kalyan Sundar Ghosh
    DOI:10.1007/s00775-016-1433-0
    日期:2017.6
    Protein aggregation, due to the imbalance in the concentration of Cu2+ and Zn2+ ions is found to be allied with various physiological disorders. Copper is known to promote the oxidative damage of beta/gamma-crystallins in aged eye lens and causes their aggregation leading to cataract. Therefore, synthesis of a small-molecule 'chelator' for Cu2+ with complementary antioxidant effect will find potential applications against aggregation of beta/gamma-crystallins. In this paper, we have reported the synthesis of different Schiff bases and studied their Cu2+ complexation ability (using UV-Vis, FT-IR and ESI-MS) and antioxidant activity. Further based on their copper complexation efficiency, Schiff bases were used to inhibit Cu2+-mediated aggregation of recombinant human gamma D-crystallin (HGD) and beta/gamma-crystallins (isolated from cataractous human eye lens). Among these synthesized molecules, compound 8 at a concentration of 100 mu M had shown 95% inhibition of copper (100 mu M)-induced aggregation. Compound 8 also showed a positive cooperative effect at a concentration of 5-15 mu M on the inhibitory activity of human alpha A-crystallin (HAA) during Cu2+-induced aggregation of HGD. It eventually inhibited the aggregation process by additional 20%. However, 50% inhibition of copper-mediated aggregation of beta/gamma-crystallins (isolated from cataractous human eye lens) was recorded by compound 8 (100 mu M). Although the reductive aminated products of the imines showed better antioxidant activity due to their lower copper complexing ability, they were found to be non-effective against Cu2+-mediated aggregation of HGD.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐